Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

In an exclusive interview, the singer discusses his new leading role in 'Cabaret,' the 'American Idol' Season 8 group chat ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...